1. Prevalence and incidence of type 2 diabetes and prediabetes CC Cowie, SS Casagrande, LS Geiss - 2021
2.What is type 2 diabetes? MD Hurtado, A Vella - Medicine, 2019 - Elsevier.
3. Kavishankar G, Lakshmidevi N, Murthy SM, Prakash H, Niranjana S. Diabetes and medicinal plants-A review. Int J Pharm Biomed Sci. 2011;2(3):65-80.
4. Chatterjee S, Khunti K, Davies MJ. Type 2 diabetes. Lancet. 2017;389(10085):2239-2251.
5. Magnuson MA. Glucokinase gene structure: functional implications of molecular genetic studies. Diabetes. 1990;39(5):523-527.
6. Magnuson M, Shelton K. An alternate promoter in the glucokinase gene is active in the pancreatic β cell. J Bio Chem. 1989;4215936:(27)2464.
7. Thorens B. GLUT2, glucose sensing and glucose homeostasis. Diabetologia. 2015;58(2):221-232.
8. Janani C, Kumari BR. PPAR gamma gene–a review. Diabetes Metab Syndr. 2015;9(1):46-50.
9. Yu Y, Du H, Wei S, Feng L, Li J, Yao F, et al. Adipocyte-derived exosomal MiR-27a induces insulin resistance in skeletal muscle through repression of PPARγ. Theranostics. 2018;8(8):2171.
10. Mukai K, Nagai S, Ohara K. Kinetic study of the quenching reaction of singlet oxygen by tea catechins in ethanol solution. Free Radic Biol Med. 2005;39(6):752-761.
11. Samuel D, Bharali D, Mousa SA. The role of nanotechnology in diabetes treatment: Current and future perspectives. Int J Nanotechnol. 2011;1(8):53-65.
12. Chacko SM, Thambi PT, Kuttan R, Nishigaki I. Beneficial effects of green tea: a literature review. Chin Med. 2010;5(1):1-9.
13. Noroozi, P., Moazenzade, E, Banaei, Mechanism and clinical aspects of the effects of chicory on diabetes. Asian J Res Med Pharm Sci. 2017;1(4):1-11.
14. Hosseini A, Hosseinzadeh H. A review on the effects of Allium sativum (Garlic) in metabolic syndrome. J Endocrinol Invest. 2015;38(11):1147-1157.
15. Noudoost B, Noori N, Amo Abedini G, Gandomi H, Akhondzadeh Basti A, Jebeli Javan A, Ghadami F. Encapsulation of green tea extract in nanoliposomes and evaluation of its antibacterial, antioxidant and prebiotic properties. J Med Plants. 2015 10;14(55):66-78.
16. Fang JY, Hung CF, Hwang TL, Huang YL. Physicochemical characteristics and in vivo deposition of liposome-encapsulated tea catechins by topical and intratumor administrations. J Drug Targeting. 2005 1;13(1):19-27.
17. Bathina, S., N. Srinivas, and U.N. Das, Streptozotocin produces oxidative stress, inflammation and decreases BDNF concentrations to induce apoptosis of RIN5F cells and type 2 diabetes mellitus in Wistar rats. Biochemical and biophysical research communications, 2017; 486(2): 406-413.
18. Gundala NK, Naidu VG, Das UN. Arachidonic acid and lipoxinA4 attenuate streptozotocin-induced cytotoxicity to RIN5 F cells in vitro and type 1 and type 2 diabetes mellitus in vivo. Nutrition. 2017;35:61-80.
19. Jahanfar S, Gahavami M, Khosravi-Darani K, Jahadi M, Mozafari MR. Entrapment of rosemary extract by liposomes formulated by Mozafari method: Physicochemical characterization and optimization. Heliyon. 2021;7(12): 1-9.
20. Patanè G, Piro S, Rabuazzo AM, Anello M, Vigneri R, Purrello F. Metformin restores insulin secretion altered by chronic exposure to free fatty acids or high glucose: A direct metformin effect on pancreatic beta-cells. Diabetes. 2000 1;49(5):735-740.
21. Guillam MT, Hümmler E, Schaerer E, Wu JY, Birnbaum MJ, Beermann F, Schmidt A, Dériaz N, Thorens B. Early diabetes and abnormal postnatal pancreatic islet development in mice lacking Glut-2. Nature genetics. 1997 1;17(3):327-330.
22. Chen T, Zhang Y, Liu Y, Zhu D, Yu J, Li G, et al. MiR-27a promotes insulin resistance and mediates glucose metabolism by targeting PPAR-γ-mediated PI3K/AKT signaling. Aging (Albany NY). 2019;11(18):7510.
23. Damasceno DC, Netto AO, Iessi IL, Gallego FQ, Corvino SB, Dallaqua B, Sinzato YK, Bueno A, Calderon ID, Rudge MV. Streptozotocin-induced diabetes models: pathophysiological mechanisms and fetal outcomes. BioMed research international. 2014;2014:8190.
24. Uldry M, Ibberson M, Hosokawa M, Thorens B. GLUT2 is a high affinity glucosamine transporter. FEBS lett. 2002;524(1-3):199-203.
25.Matschinsky FM. Glucokinase, glucose homeostasis, and diabetes mellitus. Curr Diab Rep. 2005;5A(3):171-176.
26. Sung H-Y, Hong C-G, Suh Y-S, Cho H-C, Park J-H, Bae J-H, et al. Role of (−)-epigallocatechin-3-gallate in cell viability, lipogenesis, and retinol-binding protein 4 expression in adipocytes. Naunyn Schmiedeberg’s Arch Pharmacol. 2010;382(4):303-310.
27. Hung P-F, Wu B-T, Chen H-C, Chen Y-H, Chen C-L, Wu M-H, et al. Antimitogenic effect of green tea (epigallocatechin gallate) on 3T3-L1 preadipocytes depends on the ERK and Cdk2 pathways. Am J Physiol Cell Physiol. 2005;288(5):C1094-C1108.
28. Wang CT, Chang HH, Hsiao CH, Lee MJ, Ku HC, Hu YJ, et al. The effects of green tea (epigallocatechin‐3‐gallate) on reactive oxygen species in 3T3‐L1 preadipocytes and adipocytes depend on the glutathione and 67 kDa laminin receptor pathways. Mol Nutr Food Res. 2009;53(3):349-360.
29. Eidi A, Eidi M, Esmaeili E. Antidiabetic effect of garlic (Allium sativum L.) in normal and streptozotocin-induced diabetic rats. Phytomed. 2006;13(9-10):624-629.
30. Street RA, Sidana J, Prinsloo G. Cichorium intybus: Traditional uses, phytochemistry, pharmacology, and toxicology. Evid Based Complement Alternat Med. 2013;2013:579319.
31. Hou X, Tian J, Geng J, Li X, Tang X, Zhang J, et al. MicroRNA-27a promotes renal tubulointerstitial fibrosis via suppressing PPARγ pathway in diabetic nephropathy. Oncotarget. 2016;7(30):47760.
32. Goudappala P, Gowda CY, Kashinath R. Diallyl disulfide regulates purine metabolism and their metabolites in diabetes mellitus. Indian J Physiol Pharmacol. 2021;65(1):28-34.